Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methods
AuthorsMurphy, R. G.
Roddy, A. C.
Waugh, D. J.
J, M. O. S.
McArt, D. G.
LaBonte, M. J.
AffiliationMovember FASTMAN Centre of Excellence, Patrick G Johnston Centre for Cancer Research, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7AE, UK.
MetadataShow full item record
AbstractCombining alignment-free methods for phylogenetic analysis with multi-regional sampling using next-generation sequencing can provide an assessment of intra-patient tumour heterogeneity. From multi-regional sampling divergent branching, we validated two different lesions within a patient's prostate. Where multi-regional sampling has not been used, a single sample from one of these areas could misguide as to which drugs or therapies would best benefit this patient, due to the fact these tumours appear to be genetically different. This application has the power to render, in a fraction of the time used by other approaches, intra-patient heterogeneity and decipher aberrant biomarkers. Another alignment-free method for calling single-nucleotide variants from raw next-generation sequencing samples has determined possible variants and genomic locations that may be able to characterize the differences between the two main branching patterns. Alignment-free approaches have been applied to relevant clinical multi-regional samples and may be considered as a valuable option for comparing and determining heterogeneity to help deliver personalized medicine through more robust efforts in identifying targetable pathways and therapeutic strategies. Our study highlights the application these tools could have on patient-aligned treatment indications.
CitationMurphy RG, Roddy AC, Srivastava S, Baena E, Waugh David�J, M.�O�Sullivan J, et al. Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methods. NAR Genomics and Bioinformatics. 2020;2(3):lqaa062.
JournalNAR Genomics and Bioinformatics
- SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
- Authors: Kockan C, Hach F, Sarrafi I, Bell RH, McConeghy B, Beja K, Haegert A, Wyatt AW, Volik SV, Chi KN, Collins CC, Sahinalp SC
- Issue date: 2017 Jan 1
- Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.
- Authors: Wei L, Wang J, Lampert E, Schlanger S, DePriest AD, Hu Q, Gomez EC, Murakam M, Glenn ST, Conroy J, Morrison C, Azabdaftari G, Mohler JL, Liu S, Heemers HV
- Issue date: 2017 Feb
- GENOME-WIDE ASSOCIATION MAPPING AND RARE ALLELES: FROM POPULATION GENOMICS TO PERSONALIZED MEDICINE - Session Introduction.
- Authors: DE LA Vega FM, Bustamante CD, Leal SM
- Issue date: 2011
- Nanotechnology: an evidence-based analysis.
- Authors: Medical Advisory Secretariat.
- Issue date: 2006
- Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity.
- Authors: Løvf M, Zhao S, Axcrona U, Johannessen B, Bakken AC, Carm KT, Hoff AM, Myklebost O, Meza-Zepeda LA, Lie AK, Axcrona K, Lothe RA, Skotheim RI
- Issue date: 2019 Mar